Dr. Wagner is a general internist/epidemiologist and Director of the W.A. MacColl Institute for Healthcare Innovation at the Group Health Research Institute. He is also Professor of Health Services at the University of Washington School of Public Health. Current research interests include the development and testing of population-based care models for diabetes, frail elderly, cancer, and other chronic illnesses; the evaluation of the health and cost impacts of chronic disease and cancer interventions, and interventions to prevent disability and reduce depressive symptoms in older adults. He has written two books and more than 200 journal articles. He serves on the editorial boards of Health Services Research, the Journal of Clinical Epidemiology, and BMJ-USA, and acts as a consultant to multiple Federal agencies and provate foundations. As of June 1998, he directs "Improving Chronic Illness Care (ICIC)", a national program of The Robert Wood Johnson Foundation. The overall goal of ICIC is to assist health systems improve their care of chronic illness through quality improvement and evaluation, research, and dissemination. He is also Principal Investigator of the Cancer Research Network, and NCI funded consortium of 10 HMOs conducting collaborative cancer effectiveness research. He served as Director of the research center at Group Health Cooperative since its inception 15 years ago and resigned in April 1998. He has turned his energy towards directing the MacColl Institute for Healthcare Innovation. This Institute, within Group Health Research Institute, is concerned with developing and evalutating health care innovations which serve the needs of the chronically ill.
Health services research; Health promotion and disease prevention
SciVal Experts Profile
Group Health Research Institute
1730 Minor Ave, Suite 1600
Seattle, WA 98101-1448
MD State University of New York (Buffalo), 1965 (Internal Medicine)
Chubak J, Aiello Bowles EJ, Tuzzio L, Ludman E, Rutter CM, Reid RJ, Wagner EH. Perspectives of cancer survivors on the role of different healthcare providers in an integrated delivery system. J Cancer Surviv. 2013 Dec 19. [Epub ahead of print] PMID: 24352871
Bowles EJ, Wellman R, Feigelson HS, Onitilo AA, Freedman AN, Delate T, Allen LA, Nekhlyudov L, Goddard KA, Davis RL, Habel LA, Yood MU, McCarty C, Magid DJ, Wagner EH; Pharmacovigilance Study Team. Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst. 2012 Sep 5;104(17):1293-305. doi: 10.1093/jnci/djs317. PMID: 22949432 PMCID: PMC3433392
Wagner EH, Coleman K, Reid RJ, Phillips K, Abrams MK, Sugarman JR. The changes involved in patient-centered medical home transformation. Prim Care. 2012 Jun;39(2):241-59. Epub 2012 Apr 24. PMID: 22608865
Allen LA, Yood MU, Wagner EH, Aiello Bowles EJ, Pardee R, Wellman R, Habel L, Nekhlyudov L, Davis RL, Onitilo AA, Magid DJ; for the Pharmacovigilance Research Group. Performance of Claims-based Algorithms for Identifying Heart Failure and Cardiomyopathy Among Patients Diagnosed With Breast Cancer. Med Care. 2012 May 25. [Epub ahead of print] PMID: 22643199 PMCID: PMC3482414
- Improving Chronic Illness Care (ICIC) is a national program of The Robert Wood Johnson Foundation based in Seattle at the MacColl Institute for Healthcare Innovation, at Group Health Cooperative. Its staff is dedicated to helping the millions of people in the United States who suffer from chronic illness, by teaching health care systems to keep patients as healthy as possible through planning, proven strategies and management.